2004 Annual Meeting | Treatment of ALS: Controversy and Consensus

��ɫ��

2004 Annual Meeting | Treatment of ALS: Controversy and Consensus

Date Sunday 04/25/04

Time 06:45 AM - 08:30 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Breakfast Seminar

Director(s) Robert G. Miller, MD

Topic(s) Neuromuscular and Clinical Neurophysiology (EMG)

Learning Objectives Upon completion:
Participants should be able to manage patients with ALS using modern methods of palliative care and pharmacotherapy.

CME Available No CME available

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident, Nurse

Event Timeline
06:45 AM - 07:15 AM		Pharmacotheraphy : ALS Hiroshi Mitsumoto, MD, FAAN
07:15 AM - 07:45 AM		Palliative Care : ALS Robert G. Miller, MD
07:45 AM - 08:15 AM		End of Life Issuses : ALS Wendy Johnston, MD, FRCP(C), FAAN
08:15 AM - 08:30 AM		Questions and Answers

Faculty Disclosures
Robert G. Miller, MD	The institution of Dr. Miller has received research support from Nurown.
Hiroshi Mitsumoto, MD, FAAN	Dr. Mitsumoto has nothing to disclose.
Wendy Johnston, MD, FRCP(C), FAAN	Dr. Johnston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Johnston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Inc.. Dr. Johnston has a non-compensated relationship as a Board Member with ALS Canada that is relevant to AAN interests or activities. Dr. Johnston has a non-compensated relationship as a Chair with Canadian ALS Clinical Research Group that is relevant to AAN interests or activities.
	No disclosure on file

��ɫ����

��ɫ����

��ɫ��

��ɫ��